This study found that the dramatic shift from face-to-face posthospital transitional care to telehealth did not affect 30-day readmission or mortality during the COVID-19 pandemic.
Cheng-Wei Huang, MD
Advertisement
Articles by Cheng-Wei Huang, MD
Development and Validation of the COVID-19 Hospitalized Patient Deterioration Index
ByClaudia Nau, PhD,Rebecca K. Butler, ScM,Cheng-Wei Huang, MD,Vang Kou Khang, MD,Aiyu Chen, MPH,Beth Creekmur, MA,Benjamin Broder, MD, PhD,Christopher Subject, MD,Adam L. Sharp, MD, MSc,Luis M. Moreta-Sainz, MD,Joon S. Park, MD,Akshay J. Manek, MD,Robert M. Cooper, MD,Sergio M. Mendoza, MD,Gang Luo, PhD,Michael K. Gould, MD, MS
The authors developed and validated an accurate, well-calibrated, easy-to-implement COVID-19 hospitalized patient deterioration index to identify patients at high or low risk of clinical deterioration.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Medicaid MFN Pricing Could Save $8.6 Billion
2
CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks
3
Active US Drug Shortages Rise for Third Straight Quarter
4
Access Barriers, Not Science, Slow Retina Care: Paul Hahn, MD
5